Managing Elevated Glucose Levels to Prevent Adverse Effects on Potassium Levels

Relationship Between Glucose and Potassium

Hyperglycemia can lead to potassium disturbances, particularly when insulin therapy is initiated to treat elevated glucose levels 2
Hypokalaemia is common (occurring in about 50% of cases) during treatment of hyperglycemic crises, and severe hypokalaemia (<2.5 mEq/L) is associated with increased inpatient mortality 3

The European Society of Cardiology recommends maintaining glucose concentrations ≤11.0 mmol/L (200 mg/dL) while avoiding hypoglycemia <5 mmol/L (90 mg/dL) 1
For most hospitalized patients, target glucose ranges between 7.8 and 10.0 mmol/L (140-180 mg/dL), as suggested by the European Association for the Study of Diabetes 2
In patients with severe comorbidities or where frequent monitoring is not feasible, slightly higher glucose ranges up to 11.1 mmol/L (200 mg/dL) may be acceptable, according to the American Diabetes Association 4

When using insulin to manage hyperglycemia, careful monitoring of potassium concentrations is essential, as recommended by the American Heart Association 3
For critically ill patients or those with hyperglycemic crises, continuous insulin infusion is the preferred regimen, as stated by the Society of Critical Care Medicine 3
For patients with ischemic events (myocardial infarction or stroke), rapid control of glucose values is warranted, but intensive glucose lowering has not shown additional benefit and may increase hypoglycemia risk, according to the American College of Cardiology 3
The European Society of Cardiology recommends avoiding routine glucose-insulin-potassium infusion as it is not indicated and potentially harmful 1, 5

Measure glycemia at initial evaluation in all patients with elevated glucose, as recommended by the American Diabetes Association 1
Monitor potassium levels closely when initiating insulin therapy for hyperglycemia, as suggested by the European Association for the Study of Diabetes 3
In patients receiving thrombolytic therapy with glucose >140 mg/dL, monitor glucose every 1-2 hours, according to the American Heart Association 6
For other hospitalized patients with hyperglycemia, monitor glucose every 6 hours in the first 24-48 hours, as recommended by the Society of Hospital Medicine 6

In STEMI patients, hyperglycemia is associated with adverse prognosis in both diabetic and non-diabetic patients, as stated by the American College of Cardiology 5
Hyperglycemia predicts short-term prognosis and is associated with larger infarct size, according to the European Society of Cardiology 5
Use a dose-adjusted insulin infusion with careful glucose monitoring to maintain target levels while avoiding hypoglycemia, as recommended by the American Heart Association 1

Elevated glucose levels in stroke patients are associated with neurological worsening, as suggested by the American Stroke Association 7
Treatment should be initiated when blood glucose exceeds 200 mg/dL, according to the American Heart Association 7
A reasonable goal is to treat elevated glucose concentrations to 140-180 mg/dL, as recommended by the American Stroke Association 7, 8
Hyperglycemia in stroke patients is associated with increased risk of hemorrhagic transformation after thrombolytic therapy, as stated by the American Heart Association 6

When transitioning from continuous insulin infusion to subcutaneous insulin, estimate requirements based on the average insulin infused during the previous 12 hours, as suggested by the European Association for the Study of Diabetes 3
Consider stable glucose measurements for at least 4-6 hours consecutively before transition, according to the American Diabetes Association 3

Hypoglycemia must be avoided as it can be more immediately dangerous than moderate hyperglycemia, as recommended by the European Society of Cardiology 1, 2
Sliding scale insulin alone (reactive approach) is not recommended for managing hyperglycemia, as stated by the American Diabetes Association 3